StockData
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc. (PRAX) stock

PRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$310.27−17.86 (-5.44%)

Close on Nov 16, 2026Market cap $8.66BP/E –Yield –

Praxis Precision Medicines total assets

Total assets on the balance sheet at the end of each period.

Praxis Precision Medicines's total assets was $1.39B at Jun 30, 2026. For fiscal 2025 it was $937.91M, up 94.1% from the year before. The highest annual figure on record is $937.91M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$937.91M+94.1%
FY2024Dec 31, 2024$483.11M+449.3%
FY2023Dec 31, 2023$87.95M-23.6%
FY2022Dec 31, 2022$115.13M-60.7%
FY2021Dec 31, 2021$292.75M-3.4%
FY2020Dec 31, 2020$303.18M+535.7%
FY2019Dec 31, 2019$47.69M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.39B+207.0%
Q1 FY2026Mar 31, 2026$1.46B+205.0%
Q4 FY2025Dec 31, 2025$937.91M+94.1%
Q3 FY2025Sep 30, 2025$396.39M-4.8%
Q2 FY2025Jun 30, 2025$452.83M+2.7%
Q1 FY2025Mar 31, 2025$478.74M+91.2%
Q4 FY2024Dec 31, 2024$483.11M+449.3%
Q3 FY2024Sep 30, 2024$416.26M+290.0%
Q2 FY2024Jun 30, 2024$441.06M+230.4%
Q1 FY2024Mar 31, 2024$250.41M+154.5%
Q4 FY2023Dec 31, 2023$87.95M-23.6%
Q3 FY2023Sep 30, 2023$106.73M-22.0%
Q2 FY2023Jun 30, 2023$133.50M-26.0%
Q1 FY2023Mar 31, 2023$98.38M-58.9%
Q4 FY2022Dec 31, 2022$115.13M-60.7%
Q3 FY2022Sep 30, 2022$136.90M-57.8%
Q2 FY2022Jun 30, 2022$180.42M-49.0%
Q1 FY2022Mar 31, 2022$239.50M-14.2%
Q4 FY2021Dec 31, 2021$292.75M-3.4%
Q3 FY2021Sep 30, 2021$324.41M+171.4%
Q2 FY2021Jun 30, 2021$353.51M+641.2%
Q1 FY2021Mar 31, 2021$279.25M–
Q4 FY2020Dec 31, 2020$303.18M–
Q3 FY2020Sep 30, 2020$119.55M–
Q4 FY2019Dec 31, 2019$47.69M–

More Praxis Precision Medicines figures

See a number that looks wrong?